Overexpression and EGFR phosphorylation are frequently detected in several cancers, such as head and neck squamous cell carcinoma (HNSCC), and lung, breast, prostate, ovary, and bladder cancers [15]–[18]. Here, EGFR is linked to head and neck squamous cell carcinoma.